1-methyl-4-phenylpyridinium has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badisa, RB; Latinwo, LM; Mina, DA; Soliman, KF | 1 |
| Fridman, R; Guo, Y; Kanemoto, T; Marini, AM; Martin, GR; Passaniti, A | 1 |
2 other study(ies) available for 1-methyl-4-phenylpyridinium and Cancer of Lung
| Article | Year |
|---|---|
Selective anticancer activity of neurotoxin 1-methyl-4-phenylpyridinium on non-small cell lung adenocarcinoma A549 cells.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Survival; Glutathione; Hepatocytes; Humans; Lung Neoplasms; Mitochondria; Rats | 2014 |
The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antineoplastic Agents; Carcinoma, Small Cell; DNA, Neoplasm; Gene Expression; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Proteins; Nerve Tissue Proteins; Thymidine; Tumor Cells, Cultured | 1992 |